Clinical Trial Update: An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome [Phase 2]

View source ↗

Summary

This update reports results from an open-label, multicenter Phase 2 trial of eculizumab in pediatric patients with atypical hemolytic-uremic syndrome; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome

Drugs mentioned

• Eculizumab (eculizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Atypical Hemolytic-Uremic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2015-04-29